Pleiotropic effects of GLP-1 treatment on renal risk factors in type 2 diabetes

被引：0

作者：

Petersen, E. H. ^{[1
]}

von Scholten, B. J. ^{[1
]}

Lindhardt, M. ^{[1
]}

Persson, F. ^{[1
]}

Hansen, T. W. ^{[1
]}

Rossing, P. ^{[1
,2
]}

机构：

[1] Steno Diabet Ctr, Gentofte, Denmark

[2] Novo Nordisk Fdn Ctr Metab Res, Copenhagen, Denmark

来源：

DIABETOLOGIA | 2016年 / 59卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

216

引用

页码：S110 / S111

页数：2

共 50 条

[41] Long acting GLP-1 for the treatment of type I diabetes
Reichstetter, Sandra
Castillo, Gerardo
Medarova, Zdravka
Moore, Anna
Perfetti, Riccardo
Leahy, Mark
Bolotin, Elijah
DIABETES, 2007, 56 : A73 - A73
[42] Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future
Caruso, Irene
Giorgino, Francesco
ENDOCRINE, 2024, 84 (03) : 822 - 835
[43] GLP-1 agonists in type 1 diabetes
Pettus, Jeremy
Hirsch, Irl
Edelman, Steven
CLINICAL IMMUNOLOGY, 2013, 149 (03) : 317 - 323
[44] Acute Metabolic Effects of GLP-1 Analogue in Type 1 Diabetes
Ghazi, Tara
Rink, Linda
Sherr, Jennifer L.
Herold, Kevan C.
DIABETES, 2013, 62 : A264 - A264
[45] Relationship between GLP-1 and Inflammatory Factors in Type 2 Diabetes with Metabolic Syndrome
Jiang, Hong
Yang, Yuzhi
Feng, Kun
Wang, Dan
DIABETES, 2011, 60 : A693 - A693
[46] Pleiotropic actions of GLP-1 RA
Cho, Young Min
DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S19 - S19
[47] GASTROPARESIS RISK IN PATIENTS WITH TYPE 2 DIABETES PRESCRIBED GLP-1 RECEPTOR AGONISTS
Qapaja, Thabet
Hamid, Osama
Abu-Rumaileh, Mohammed
Kaya, Gizem
Saleh, Sherif
Garg, Samita
GASTROENTEROLOGY, 2024, 166 (05) : S204 - S204
[48] Liraglutide. GLP-1 receptor agonist, Treatment of type 2 diabetes, Treatment of obesity
Gallwitz, B.
DRUGS OF THE FUTURE, 2008, 33 (01) : 13 - 20
[49] Liraglutide: once-daily GLP-1 agonist for the treatment of type 2 diabetes
Ryan, Gina J.
Hardy, Yolanda
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (03) : 260 - 274
[50] Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK
Kristina S. Boye
Dara Stein
Louis S. Matza
Jessica Jordan
Ren Yu
Kirsi Norrbacka
Syed Wasi Hassan
Luis-Emilio García-Pérez
Drugs in R&D, 2019, 19 : 213 - 225

← 1 2 3 4 5 →